Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients

Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?

(2013) Roxana Chiorean et al.   BREAST

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome

(2012) Jia Xu et al.   BMC CANCER

HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro

(2012) Xiao-lin Lin et al.   Chinese Journal of Cancer Research

Effect of trastuzumab on Notch-1 signaling pathway in breast cancer SK-BR3 cells

(2012) Ming Han et al.   Chinese Journal of Cancer Research

Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer

(2012) F. Andre et al.   CLINICAL CANCER RESEARCH

Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis

(2012) Michail Ignatiadis et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating tumour cells in non-metastatic breast cancer: a prospective study

(2012) Anthony Lucci et al.   LANCET ONCOLOGY

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients

(2011) Georg Göbel et al.   BREAST CANCER RESEARCH AND TREATMENT

Genome-wide Analyses of Transcription Factor GATA3-Mediated Gene Regulation in Distinct T Cell Types

(2011) Gang Wei et al.   IMMUNITY

NOTCH1 regulates migration and invasion of skin cancer cells by E-cadherin repression

(2011) Zhipeng Wang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling

(2011) C-R Pradeep et al.   ONCOGENE

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma

(2011) Fabien Reyal et al.   PLoS One

14-3-3  regulates B-cell homeostasis through stabilization of FOXO1

(2011) Y.-W. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy

(2011) Carsten Denkert et al.   Seminars in Immunopathology

Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study

(2010) K. M. O'Brien et al.   CLINICAL CANCER RESEARCH

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

(2010) Fiona M. Blows et al.   PLOS MEDICINE

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

(2009) A Daskalaki et al.   BRITISH JOURNAL OF CANCER

Prognostic significance of RASSF1A promoter methylation in operable breast cancer

(2009) Magdalini Kioulafa et al.   CLINICAL BIOCHEMISTRY

Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer

(2008) Simon J. Crabb et al.   Clinical Breast Cancer

Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer

(2008) M. Han et al.   CLINICAL CANCER RESEARCH